Depreotide
Depreotide is a radiopharmaceutical used primarily in the field of nuclear medicine for diagnostic imaging. It is a synthetic peptide that binds to somatostatin receptors, which are often overexpressed in certain types of tumors, particularly in the lungs. Depreotide is labeled with the radioactive isotope Technetium-99m (Tc-99m), allowing it to be used in single-photon emission computed tomography (SPECT) imaging.
Mechanism of Action[edit | edit source]
Depreotide functions by targeting somatostatin receptors, which are G-protein coupled receptors found on the surface of some tumor cells. When depreotide binds to these receptors, it allows for the visualization of tumors through SPECT imaging. The radiolabeled depreotide emits gamma rays, which are detected by the SPECT camera, providing a detailed image of the tumor's location and size.
Clinical Applications[edit | edit source]
Depreotide is primarily used in the evaluation of pulmonary nodules to differentiate between benign and malignant lesions. It is particularly useful in the diagnosis of lung cancer, as many lung tumors express somatostatin receptors. The imaging results can help guide further diagnostic procedures, such as biopsy, or therapeutic decisions.
Advantages and Limitations[edit | edit source]
Advantages[edit | edit source]
- Non-invasive imaging technique.
- Provides functional imaging, which can be more informative than anatomical imaging alone.
- Useful in identifying somatostatin receptor-positive tumors.
Limitations[edit | edit source]
- Limited to tumors that express somatostatin receptors.
- Exposure to radiation, although minimal, is a consideration.
- Not as widely available as other imaging modalities.
Safety and Side Effects[edit | edit source]
Depreotide is generally well-tolerated, with few reported side effects. The most common side effects are related to the injection process, such as pain or swelling at the injection site. As with any radiopharmaceutical, there is a small risk of radiation exposure, but the benefits of accurate diagnosis typically outweigh these risks.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
